CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Effect of multiple intra-articular injections of polynucleotides on treatment of intractable knee osteoarthritis: A case report.

Medicine (Baltimore) 2017 December
RATIONALE: Knee osteoarthritis (KOA) is a chronic joint degenerative disease. Intra-articular injection (IAI) of hyaluronic acid (HA) is widely used to treat KOA. However, some HA injections have no effect at all. Polynucleotides (PN) are recently noted as a valid substitute for HA.

PATIENT CONCERNS: A 61-year-old female was admitted to the pain center with symptoms of pain over the knee and warmth feeling with stiffness in the left knee. The patient reported chronic severe pain in the left knee area despite 6 times IAI of HA. She had past medical history of breast cancer and thyroid cancer.

DIAGNOSES: She was diagnosed as having KOA.

INTERVENTIONS: Ultrasound-guided IAI of PN was carried out 3 times in 3 weeks.

OUTCOMES: She was followed-up for more than 5 months with good improvement in intractable knee pain without any adverse event.

LESSONS: IAI of PN is an efficient therapeutic option for KOA treatment if HA injection is unsuccessful.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app